about
Type 2 diabetes mellitus phenotype and graft survival after islet transplantationLipotoxicity and decreased islet graft survivalRestoration of hypoglycemia awareness after islet transplantation.Improved long-term health-related quality of life after islet transplantation.Long-term insulin independence and improvement in insulin secretion after supplemental islet infusion under exenatide and etanercept.Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction.Nonalbumin proteinuria in islet transplant recipients.Late Epstein Barr virus reactivation in islet after kidney transplantation.Clinical use of fructosamine in islet transplantation.
P50
Q33609022-21173B00-423D-4EDE-889C-68B5727DA4FBQ33683805-971A668A-B938-4563-A2F3-F044F95E603CQ36945277-BE6E84E0-61BB-4C74-A13E-D0ACE97A50D4Q37341196-447431E5-038F-444A-A0D2-73EBA0ABEFC6Q37381194-6C90BA00-8081-484D-A99B-42A86A65B398Q43225003-F320A679-9829-4995-9BE7-375E64819F92Q43251594-82A4F9A3-9A72-4B17-BB94-301879997CE5Q45388737-7EBBE578-CE07-40EB-B1DF-6B4458F70491Q45923894-E81253AD-53B8-42AB-A481-F470BAB482D7
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Thipaporn Tharavanij
@ast
Thipaporn Tharavanij
@en
Thipaporn Tharavanij
@es
Thipaporn Tharavanij
@nl
type
label
Thipaporn Tharavanij
@ast
Thipaporn Tharavanij
@en
Thipaporn Tharavanij
@es
Thipaporn Tharavanij
@nl
prefLabel
Thipaporn Tharavanij
@ast
Thipaporn Tharavanij
@en
Thipaporn Tharavanij
@es
Thipaporn Tharavanij
@nl
P106
P1153
24336490900
P31
P496
0000-0001-5431-0440